Micro-K for Liquid Suspension
(Generic versions may still be available.)
In addition to bleeding and ulceration, perforation and obstruction have been reported in patients treated with solid KCl dosage forms, and may occur with Micro-K LS.
The most common adverse reactions to the oral potassium salts are nausea, vomiting, flatulence, abdominal pain/discomfort, and diarrhea. These symptoms are due to the irritation of the gastrointestinal tract and are best managed by taking the dose with meals, or reducing the amount taken at one time.
In a controlled clinical study, Micro-K LS was associated with an increased frequency of gastrointestinal intolerance (e.g., diarrhea, loose stools, abdominal pain, etc.) compared to equal doses (100 mEq/day) of Micro-K Extencaps (see WARNINGS, Diarrhea or Dehydration). This finding was attributed to an inactive ingredient used in the Micro-K LS formulation that is not present in the Micro-K Extencaps formulation.
Read the Micro-K for Liquid Suspension (potassium chloride extended release formulation for liquid suspension) Side Effects Center for a complete guide to possible side effects
Additional Micro-K for Liquid Suspension Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.